Mark Wrona

887 total citations
33 papers, 642 citations indexed

About

Mark Wrona is a scholar working on Molecular Biology, Spectroscopy and Pharmacology. According to data from OpenAlex, Mark Wrona has authored 33 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Spectroscopy and 7 papers in Pharmacology. Recurrent topics in Mark Wrona's work include Metabolomics and Mass Spectrometry Studies (9 papers), Analytical Chemistry and Chromatography (9 papers) and Mass Spectrometry Techniques and Applications (9 papers). Mark Wrona is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Analytical Chemistry and Chromatography (9 papers) and Mass Spectrometry Techniques and Applications (9 papers). Mark Wrona collaborates with scholars based in United States, Canada and United Kingdom. Mark Wrona's co-authors include Kevin P. Bateman, Kate Yu, Russell J. Mortishire‐Smith, José Castro‐Perez, John P. Shockcor, Timo Mauriala, Renata M. Oballa, Deborah A. Nicoll‐Griffith, Desmond O’Connor and Giorgis Isaac and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Mark Wrona

33 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wrona United States	13	382	261	98	73	63	33	642
Tianyi Zhang China	13	335 0.9×	160 0.6×	40 0.4×	71 1.0×	27 0.4×	40	601
Jan Felix Joseph Germany	13	189 0.5×	140 0.5×	47 0.5×	26 0.4×	46 0.7×	23	599
Birthe Schubert Austria	13	370 1.0×	253 1.0×	47 0.5×	27 0.4×	56 0.9×	21	776
Charles H. Phoebe United States	15	460 1.2×	185 0.7×	96 1.0×	241 3.3×	30 0.5×	26	767
Markus Dachtler Germany	13	275 0.7×	126 0.5×	20 0.2×	78 1.1×	40 0.6×	21	636
M. Reza Anari Canada	13	222 0.6×	161 0.6×	35 0.4×	68 0.9×	145 2.3×	17	647
Ksenija Kuhajda Serbia	15	205 0.5×	157 0.6×	47 0.5×	127 1.7×	55 0.9×	42	606
Aleksanteri Petsalo Finland	17	299 0.8×	72 0.3×	58 0.6×	27 0.4×	262 4.2×	24	682
Wolfgang Muster Switzerland	13	220 0.6×	81 0.3×	65 0.7×	83 1.1×	75 1.2×	26	742
F.A.A. van Acker Netherlands	11	282 0.7×	58 0.2×	73 0.7×	133 1.8×	171 2.7×	13	830

Countries citing papers authored by Mark Wrona

Since Specialization

Citations

This map shows the geographic impact of Mark Wrona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wrona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wrona more than expected).

Fields of papers citing papers by Mark Wrona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wrona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wrona. The network helps show where Mark Wrona may publish in the future.

Co-authorship network of co-authors of Mark Wrona

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wrona. A scholar is included among the top collaborators of Mark Wrona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wrona. Mark Wrona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kogan, Andrei, et al.. (2025). 3D in vitro blood–brain barrier models: recent advances and their role in brain disease research and therapy. Frontiers in Pharmacology. 16. 1637602–1637602. 1 indexed citations

Chen, Zhuo, et al.. (2022). Systematic optimization of targeted and multiplexed MS-based screening workflows for protein biomarkers. Bioanalysis. 14(6). 341–356. 1 indexed citations

Chen, Zhuo, Yun W. Alelyunas, Mark Wrona, et al.. (2019). Microflow UPLC and High-Resolution MS as a Sensitive and Robust Platform for Quantitation of Intact Peptide Hormones. Bioanalysis. 11(13). 1275–1289. 12 indexed citations

Doneanu, Catalin E., Jing Fang, Yun W. Alelyunas, et al.. (2018). An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry. Journal of Visualized Experiments. 7 indexed citations

Deevska, Gergana M., Alexander Karakashian, Giorgis Isaac, et al.. (2017). Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1. Journal of Biological Chemistry. 292(12). 5110–5122. 18 indexed citations

Salazar, Carolina, Michael D. Jones, Drew Sturtevant, et al.. (2017). Development and application of sub‐2‐μm particle CO ₂ ‐based chromatography coupled to mass spectrometry for comprehensive analysis of lipids in cottonseed extracts. Rapid Communications in Mass Spectrometry. 31(7). 591–605. 13 indexed citations

Avula, Bharathi, et al.. (2016). Metabolomics Based UHPLC-QToF-MS Approach for the Authentication of Various Botanicals and Dietary Supplements. Planta Medica. 82(5). 3 indexed citations

Wrona, Mark, et al.. (2016). Mass detection for chromatographers: Benefits for the analysis of herbal medicines. Planta Medica. 81(S 01). S1–S381. 1 indexed citations

Wrona, Mark, et al.. (2016). Chemical profiling of Actaea species and commercial products using UPLC-QTof-MS. Planta Medica. 81(S 01). S1–S381. 1 indexed citations

10.

Wei, Tong, Swapan K. Chowdhury, Mark Wrona, & Kevin P. Bateman. (2012). Coupling of Uhplc With Fast Fraction Collection–Microplate Scintillation Counting And Ms For Radiolabeled Metabolite Profiling. Bioanalysis. 4(11). 1299–1309. 7 indexed citations

11.

Trimble, Laird A., Mark W. Sumarah, Barbara A. Blackwell, Mark Wrona, & J. David Miller. (2011). Characterization of (16R) and (16S)-hydroxyroquefortine C; diastereomeric metabolites from Penicillium crustosum DAOM 215343. Tetrahedron Letters. 53(8). 956–958. 10 indexed citations

12.

Colucci, John, Michael J. Boyd, Carl Berthelette, et al.. (2010). Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl)amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain. Bioorganic & Medicinal Chemistry Letters. 20(12). 3760–3763. 29 indexed citations

13.

Burch, Jason D., John Colucci, Claudio F. Sturino, et al.. (2010). Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 21(3). 1041–1046. 12 indexed citations

14.

Boyd, Michael J., Carl Berthelette, Patsy Clark, et al.. (2010). A novel series of potent and selective EP4 receptor ligands: Facile modulation of agonism and antagonism. Bioorganic & Medicinal Chemistry Letters. 21(1). 484–487. 18 indexed citations

15.

Blouin, Marc, Yongxin Han, Jason D. Burch, et al.. (2010). The Discovery of 4-{1-[({2,5-Dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic Acid (MK-2894), A Potent and Selective Prostaglandin E₂Subtype 4 Receptor Antagonist. Journal of Medicinal Chemistry. 53(5). 2227–2238. 29 indexed citations

16.

Burch, Jason D., Michel Belley, Réjean Fortin, et al.. (2008). Structure–activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP4 receptor. Bioorganic & Medicinal Chemistry Letters. 18(6). 2048–2054. 15 indexed citations

17.

Wrona, Mark, Apolonia Sieprawska, Waldemar Tejchman, & Maria Filek. (2007). The influence of selenium compounds on the permeability of wheat callus cell plasma membranes in the presence of cadmium ions. Acta Physiologiae Plantarum. 29. 1 indexed citations

18.

Bateman, Kevin P., José Castro‐Perez, Mark Wrona, et al.. (2007). MS ^E with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Communications in Mass Spectrometry. 21(9). 1485–1496. 204 indexed citations

19.

Wrona, Mark, Timo Mauriala, Kevin P. Bateman, Russell J. Mortishire‐Smith, & Desmond O’Connor. (2005). ‘All‐in‐One’ analysis for metabolite identification using liquid chromatography/hybrid quadrupole time‐of‐flight mass spectrometry with collision energy switching. Rapid Communications in Mass Spectrometry. 19(18). 2597–2602. 143 indexed citations

20.

Wrona, Mark, Gregory B. Gloor, Farideh Jalilehvand, et al.. (2004). Solution NMR Structure and X-ray Absorption Analysis of the C-Terminal Zinc-Binding Domain of the SecA ATPase. Biochemistry. 43(29). 9361–9371. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact